If your provider just told you you’ll be doing NSTs in the third trimester, it can feel like: Wait… is my baby not okay? Did I do something wrong?
Take a breath. A non stress test (also written as nonstress test or non stress test NST) is one of the most common forms of antepartum fetal surveillance in high risk pregnancies—and gestational diabetes can put you in that “extra monitoring” bucket even when your blood sugar is well controlled.
This post will walk you through what an NST is, when it’s typically recommended in pregnancies complicated by gestational diabetes mellitus (GDM), what “reactive” vs non reactive tracing means, and what usually happens next.
(Julija note: Extra monitoring is not a punishment. It’s your team using more data to protect your baby’s health—and your peace of mind.)
A non stress test (NST) is a simple, non-invasive fetal monitoring test that measures your baby’s fetal heart rate response to fetal movement.
The goal is to check fetal well being—specifically, whether the baby is likely getting enough oxygen (screening for concerns like fetal hypoxia).
In general clinical practice, a baby is considered reactive when the tracing shows heart rate accelerations that match movement.
A reactive NST is reassuring because it suggests:
Good oxygenation
A healthy nervous system response
Lower immediate risk of serious fetal complications
Most diabetic pregnancies (including gestational diabetes and pre-existing diabetes mellitus) get more monitoring because diabetes in pregnancy can be associated with an elevated risk of certain adverse pregnancy outcomes.
This doesn’t mean those outcomes will happen to you. It means your care team is watching for them.
Potential risk factors and complications that can increase the need for fetal surveillance include:
Needing insulin therapy (or other medication)
Poorly controlled blood sugar / high blood sugar levels
Maternal obesity
Blood pressure issues or pre eclampsia
Twin pregnancy
Concerns about fetal growth or fetal size (too small or too large)
Changes in amniotic fluid / amniotic fluid volume
In some clinical studies, pregnancies complicated by diabetes have shown a significant increase in certain adverse effects (including higher rates of cesarean sections, shoulder dystocia, and other perinatal outcomes)—especially when glycemic control is not optimal.
Julija note: The goal here is not to scare you. It’s to explain why providers monitor more closely—because catching problems early improves maternal and neonatal outcomes.
NSTs are not required for all well-controlled gestational diabetes without complications—but practices vary wildly.
Often, providers still recommend NSTs for:
Any GDM diagnosis (even diet controlled)
Anyone in the “diabetic group” at their clinic
Anyone with additional risk factors
So if you’re thinking, “My numbers are fine—why weekly NST?” you’re not being difficult. It’s a fair question.
There isn’t one universal start date.
Many clinics begin NSTs somewhere around 32 to 36 weeks of gestational age, depending on:
Whether you’re on insulin therapy
Overall pregnancy complications
Fetal growth scan results
You may hear:
Weekly NST
Twice a week NSTs (often for higher-risk situations)
Some guidance referenced in clinical practice (including ACOG practice bulletin discussions) commonly ties surveillance to medication use and glycemic control.
You’ll usually be seated or lying slightly tilted.
Two monitors are placed on your belly:
One measures baby’s heart rate
One measures uterine contractions (or uterine activity)
You may also be given a button to press when you feel movement.
Most NSTs take about 20–40 minutes.
A non reactive NST means the tracing didn’t meet the criteria for “reactive” during the test window.
Important: A non-reactive NST does not automatically indicate fetal distress.
Common reasons for a non-reactive result include:
Baby is asleep
You tested right after a busy day and baby is quieter
Earlier gestational age
Medications
Normal variation in fetal sleep cycles
Your provider may do further evaluation, such as:
Extending the NST longer
Using a sound/vibration to wake baby
A biophysical profile (BPP)
A growth scan
Checking amniotic fluid volume
Sometimes a contraction stress test (less common)
The goal is to gather more data—not to jump straight to worst-case conclusions.
NST is one tool in fetal surveillance.
Other tests your provider might mention:
Biophysical profile (BPP): ultrasound + NST components
Doppler ultrasound (in certain high risk pregnancies)
Ultrasound checks for fetal growth, fetal size, and amniotic fluid
BPP looks at things like:
Fetal breathing movements
Movement and tone
Amniotic fluid
Many providers also recommend fetal kick counts (tracking fetal movement patterns).
Kick counts aren’t about obsessing over a number—they’re about noticing your baby’s normal.
If movement is significantly decreased, contact your healthcare provider.
NSTs themselves don’t automatically change delivery timing—but the results can influence decisions.
You may hear general timing ranges like:
Delivery around 39 weeks for many GDM pregnancies with good control
Earlier delivery (often 37–38 weeks) if blood sugar is poorly controlled or there are complications
Your plan depends on your full picture: blood sugar control, medications, blood pressure, fetal growth, amniotic fluid, and overall maternal and neonatal outcomes.
Julija note: If you’re seeing “39 weeks” everywhere online, remember: guidelines are averages. Your provider’s job is to tailor to your pregnancy.
“Why am I considered high risk—GDM alone, or other risk factors?”
“How often will I need NSTs—weekly or twice a week?”
“What result would lead to additional tests?”
“Will we also do a growth scan or BPP?”
“What’s the plan for delivery timing if everything stays stable?”
Most women with gestational diabetes go on to have a healthy baby.
NSTs are one of those annoying-but-reassuring parts of late pregnancy: more appointments, more waiting… but also more confirmation that baby is doing okay.
1. What is a non stress test (NST) in pregnancy?
A non stress test (NST) is a non-invasive fetal monitoring test that tracks your baby’s fetal heart rate and how it responds to fetal movement. It’s used as part of antepartum fetal surveillance to check fetal well being.
2. Why do I need NSTs with gestational diabetes?
Gestational diabetes mellitus can place a pregnancy in a higher-risk category, especially if there are additional risk factors (insulin therapy, high blood sugar levels, blood pressure issues, maternal obesity, twin pregnancy, or concerns about fetal growth or amniotic fluid volume). NSTs give your healthcare provider extra reassurance about baby’s health.
3. Do you need NSTs for diet-controlled gestational diabetes?
NSTs are not required for all well-controlled, diet controlled gestational diabetes without complications—but clinic protocols vary. Often, providers still recommend weekly NSTs in the third trimester based on their clinical practice.
4. When do NSTs start with gestational diabetes?
Many clinics start NSTs around 32 to 36 weeks of gestational age, depending on whether you’re on insulin therapy and whether there are pregnancy complications. Some people do weekly NST; higher-risk situations may be twice a week.
5. What does a non-reactive NST mean?
A non reactive NST means the tracing didn’t meet the criteria to be considered reactive during the test window. It does not automatically mean fetal distress—babies can be asleep, quieter that day, or need more time.
6. What happens after a non-reactive NST?
Your provider may extend the NST, try to wake baby, or recommend additional tests such as a biophysical profile (BPP), a growth scan, or checking amniotic fluid volume. This is further evaluation to gather more information.
7. NST vs BPP: what’s the difference?
An NST focuses on fetal heart rate response to movement. A biophysical profile (BPP) combines ultrasound observations (including fetal breathing movements and amniotic fluid) with NST information to give a broader picture of fetal well being.
Get a Free 20-Day Shopping List
